← Eichor
Study identifier: NCT06804057 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

Condition: Systemic Lupus Erythematosus  ·  Sponsor: CorEvitas

PhaseN/A
Planned participants1000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Prospective, observational registry for subjects with SLE under the care of a rheumatology provider. Longitudinal data are collected from both subjects and their treating rheumatology provider during routine clinical encounters using a structured and standardized data collection method.

This description comes directly from the study's public registry record.

Talk to the study team

CorEvitas, LLC  ·  (508) 408-5435  ·  corevitasregistrytrials@corevitas.com

Always discuss trial participation with your own doctor first.

Locations (1)

CorEvitasWaltham, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06804057